p53 down-regulates matrix metalloproteinase-1 by targeting the communications between AP-1 and the basal transcription complex

Journal of Cellular Biochemistry

Volumn 92, Issue 2, 2004, Pages 258-269

  Sun, Yubo ^a   Zeng, Xiao Rong ^b   Wenger, Leonor ^b   Firestein, Gary S ^c   Cheung, Herman S ^b,d  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b University of Miami College of Engineering   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Coactivator protein p300; Matrix metalloproteinase 1; Transcription; Tumor suppressor protein p53

Indexed keywords

INTERSTITIAL COLLAGENASE; MESSENGER RNA; PROTEIN C JUN; PROTEIN P300; PROTEIN P53; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR ELK 1; TRANSCRIPTION FACTOR GAL4; MULTIPROTEIN COMPLEX; NUCLEAR PROTEIN; TRANSACTIVATOR PROTEIN;

ARTICLE; DOWN REGULATION; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSCRIPTION; PRIORITY JOURNAL; PROTEIN BINDING; BINDING SITE; CHEMISTRY; GENETICS; HELA CELL; HUMAN; METABOLISM; MUTATION; PHOSPHORYLATION; PROMOTER REGION;

BINDING SITES; DOWN-REGULATION; HELA CELLS; HUMANS; MATRIX METALLOPROTEINASE 1; MULTIPROTEIN COMPLEXES; MUTATION; NUCLEAR PROTEINS; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-JUN; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 15244360282     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20044     Document Type: Article

References (40)

1. Albanese C, D'Amico M, Reutens AT, Fu M, Watanabe G, Lee RJ, Kitsis RN, Henglein B, Avantaggiati M, Somasundaram K, Thimmapaya B, Pestell RG. 1996. Activation of the cyclin D1 gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis. J Biol Chem 274:34186-34195.
2. Howard B, Levine AS. 1996. The SV40 large T antigen and adenovirus E1a oncoproteins interact with distinct isoforms of the transcriptional co-activator, p300. EMBO J 15:2236-2248.
3. Avantaggiati ML, Ogryzko V, Gardner K, Giordano A, Levine AS, Kelly K. 1997. Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89:1175-1184.
4. Basset P, Okada A, Chenard MP, Kannan R, Stoll I, Anglard P, Bellocq JP, Rio MC. 1997. Matrix metalloproteinases as stromal effectors of human carcinoma progression: Therapeutical implications. Matrix Biol 15: 535-541.
5. Bolon I, Gouyer V, Devouassoux M, Vandenbunder B, Wernert N, Moro D, Brambilla C, Brambilla E. 1995. Expression of c-ets-1, collagenase-1, and urokinase-type plasminogen activator genes in lung carcinomas. Am J Pathol 147:1298-1310.
6. Borellini F, Glazer RI. 1993. Induction of Sp1-p53 DNA-binding heterocomplexes during granulocyte/macrophage colony-stimulating factor-dependent proliferation in human erythroleukemia cell line TF-1. J Biol Chem 268:7923-7928.
7. Chapman SC, Ayala JE, Streeper RS, Culbert AA, Eaton EM, Svitek CA, Goldman JK, Tavar JM, O'Brien RM. 1999. Multiple promoter elements are required for the stimulatory effect of insulin on human collagenase-1 gene transcription-selective effects on activator protein-1 expression may explain the quantitative difference in insulin and phorbol ester action. J Biol Chem 274:18625-18634.
8. Clore GM, Ernst J, Clubb R, Omichinski JG, Kennedy WM, Sakaguchi K, Appella E, Gronenborn AM. 1995. Refined solution structure of the oligomerization domain of the tumour suppressor p53. Nat Struct Biol 2:321-333.
9. Deb S, Jackson CT, Subler MA, Martin DW. 1992. Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells. J Virol 66: 6164-6170.
10. Eckner R, Ewen ME, Newsome D, Gerdes M, DeCaprio JA, Lawrence JB, Livingston DM. 1994. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kDa protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev 8: 869-884.
11. El-Deiry WS, Tokino T, Veculescu VE, Levy DB, Parsons R, Trent J, Lin D, Mercer WE, Kinzler KW, Vogelster B. 1993. WAF1 a potential mediator of p53 tumor suppression. Cell 75:817-825.
12. Farmer G, Friedlander P, Colgan J, Manley JL, Prives C. 1996. Transcriptional repression by p53 involves molecular interactions distinct from those with the TATA box binding protein. Nucleic Acids Res 24:4281-4288.
13. Gayther SA, Batley SJ, Linger L, Bannister A, Thorpe K, Chin SF, Daigo Y, Russell P, Wilson A, Sowter HM, Delhanty JD, Ponder BA, Kouzarides T, Caldas C. 2000. Mutations truncating the EP300 acetylase in human cancers. Nat Genet 24:300-303.
14. Giles RH, Peters DJ, Breuning MH. 1998. Conjunction dysfunction: CBP/p300 in human disease. Trends Genet 14:178-183.
15. Gutman A, Wasylyk B. 1990. The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J 9:2241-2246.
16. Hollstein M, Sidransky D, Vogelstein B, Harris CC. 1991. p53 mutations in human cancers. Science 253:49-53.
17. Johansson N, Airola K, Grenman R, Kariniemi AL, Saarialho-Kere U, Kahari VM. 1997. Expression of collagenase-3 (MMP-13) in squamous cell carcinomas of the head and neck. Am J Pathol 151:499-508.
18. Johnsen M, Lund LR, Romer J, Almholt K, Dan K. 1998. Cancer invasion and tissue remodeling: Common themes in proteolytic matrix degradation. Curr Opin Cell Biol 10:667-671.
19. Ko LJ, Prives C. 1996. p53: Puzzle and paradigm. Genes Dev 10:1054-1072.
20. Levine AJ. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323-331.
21. Lill NL, Grossman SR, Ginsberg D, DeCaprio J, Livingston DM. 1997. Binding and modulation of p53 by p300/CBP coactivators. Nature 387:823-827.
22. Liu X, Berk AJ. 1995. Reversal of in vitro p53 squelching by both TFIIB and TFIID. Mol Cell Biol 15:6474-6478.
23. Liu X, Miller CW, Koeffler PH, Berk AJ. 1993. The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription. Mol Cell Biol 13:3291-3300.
24. Miyashita T, Harigai M, Hanada M, Reed JC. 1994. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 54:3131-3135.
25. Muraoka M, Konishi M, Kikuchi-Yanoshita R, Tanaka K, Shitara N, Chong JM, Iwama T, Miyaki M. 1996. p300 gene alterations in colorectal and gastric carcinomas. Oncogene 12:1565-1569.
26. Murray G, Duncan ME, O'Neil P, Melvin WT, Fothergill JE. 1996. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 2:461-462.
27. Nuovo GJ, MacConnell PB, Simsir A, Valea F, French DL. 1995. Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinases complementary DNAs and their inhibitors with prognosis in cervical carcinomas. Cancer Res 55:257-265.
28. Ravi R, Mookerjee B, van Henshergen Y, Bedi GC, Giordano A, El-Deiry WS, Fuchs EJ, Bedi A. 1998. p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300. Cancer Res 58: 4531-4536.
29. Seto E, Usheva A, Zambetti GP, Momand J, Hokoshi N, Weinmann R, Levine AJ, Shenk T. 1992. Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc Natl Acad Sci USA 89:12028-12032.
30. Shiio Y, Yamamoto T, Yamaguchi N. 1992. Negative regulation of Rb expression by the p53 gene product. Proc Natl Acad Sci USA 89:5206-5210.
31. Sun Y, Sun YI, Wenger L, Rutter JL, Brinckerhoff CE, Cheung HS. 1999. p53 down-regulates human metalloproteinase-1 (collagenase-1) gene expression. J Biol Chem 274:11535-11540.
32. Sun Y, Cheung JM, Martel-Pelletier J, Pelletier JP, Wenger L, Altman RD, Howell DS, Cheung HS. 2000. Wild type and mutant p53 differentially regulate the gene expression of human collagenase-3 (hMMP-13). J Biol Chem 275:11327-11332.
33. Sun Y, Wenger L, Brinckerhoff CE, Misra RR, Cheung HS. 2002. Basic calcium phosphate crystals induce matrix metalloproteinase-1 through the Ras/mitogen-activated protein kinase/c-Fos/AP-1/metalloproteinase 1 pathway. Involvement of transcription factor binding sites AP-1 and PEA-3. J Biol Chem 277:1544-1552.
34. Vincenti MP, White LA, Schroen DJ, Benbow U, Brinckerhoff CE. 1996. Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): Mechanisms that control enzyme activity, transcription, and mRNA stability. Crit Rev Eukaryot Gene Exp 6:391-411.
35. Vogelstein B, Kinzler KW. 1992. p53 function and dysfunction. Cell 70:523-526.
36. Yang C, Shapiro LH, Rivera M, Kumar A, Brindle PK. 1998. A role for CREB binding protein and p300 transcriptional coactivators in Ets-1 transactivation functions. Mol Cell Biol 18:2218-2229.
37. Yao TP, Oh SP, Fuchs M, Zhou ND, Ch'ng LE, Newsome D, Bronson RT, Li E, Livingston DM, Eckner R. 1998. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93:361-372.
38. Yuan W, Condorelli G, Caruso M, Felsani A, Giordano A. 1996. Human p300 protein is a coactivator for the transcription factor MyoD. J Biol Chem 271:9009-9013.
39. Yuan ZM, Huang Y, Ishiko T, Nakada S, Utsugisawa T, Shioya H, Utsugisawa Y, Shi Y, Weichselbaum R, Kufe D. 1999. Function for p300 and not CBP in the apoptotic response to DNA damage. Oncogene 18:5714-5717.
40. Yun J, Chae HD, Choy HE, Chung J, Yoo HS, Han MH, Shin DY. 1999. p53 negatively regulates cdc2 transcription via the CCAAT-binding NF-Y transcription factor. J Biol Chem 274:29677-29682.